Virginia Giddings joined Intersect ENT in 2019 and serves as Vice President of Research & Development, driving the transformation and expansion of the company’s product portfolio. She has extensive experience in healthcare leadership, with roles in medical device, pharmaceutical and nutrition businesses. Previously she led Advanced Technologies and Innovation and the Program Management Office for Stryker Neurovascular, where she was responsible for delivering the complete product development portfolio as well as key business initiatives and commercial launch management. Prior to Stryker, Virginia ran Strategic R&D for the Nutrition division at Abbott, and played a key role in the development of Abbott’s drug eluting coronary stent and novel bioabsorbable stent. She was responsible for developing IP strategy for drug-device combination products while with ALZA, a Johnson & Johnson Pharmaceutical company. Virginia serves on the Cornell Engineering Council, President’s Council of Cornell Women and Georgia Tech-Emory Bioengineering Board. In addition, she is a Fellow of the American Institute of Medical and Biological Engineering and a co-founder of MedtechWomen, an organization dedicated to highlighting and connecting women leaders in healthcare. Virginia holds B.S. and M.Eng. degrees in Mechanical Engineering from Cornell University, and a Ph.D. in Mechanical Engineering from Stanford University.
